Treatment with cannabidiol, a selective antagonist of GPR55, counteracted these pro-atherogenic and proinflammatory O-1602-mediated effects.
Link: Activation Of GPR55 Receptors Exacerbates OxLDL-Induced Lipid Accumulation And Inflammatory Responses, While Reducing Cholesterol Efflux From Human Macrophages
Year: 2015
DOI: 10.1371/journal.pone.0126839
Possibility of efficacy for cannabis in treatment of Atherosclerosis according to the results found in this study.
CBD